Evaluating cannabis use risk reduction as an alternative clinical outcome for cannabis use disorder.
Brian J ShermanMichael J SofisJacob T BorodovskyKevin M GrayAimee L McRae-ClarkAlan J BudneyPublished in: Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors (2021)
Cannabis use risk levels, as operationalized in this study, captured reductions in use during a clinical trial. Risk level reduction was associated with functional improvement suggesting that identifying risk levels and measuring the change in levels over time may be a viable and clinically meaningful endpoint for determining treatment efficacy. (PsycInfo Database Record (c) 2021 APA, all rights reserved).